IGENICA
Igenica Biotherapeutics is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. They are the only biotherapeutic company that fully powers the ADC development spectrum from a clinically relevant approach to target and functional antibody discovery to ADC creation, accelerating development and the delivery of effective therapies to patients. Founded in 2009, Igenica is led by a proven team of leaders that have demonstrated succ... ess in antibody drug discovery, clinical development and commercialization. Their leadership team has played a seminal role in six out of the 36 currently approved antibody therapeutic products. Based in Burlingame, Calif., they are well-funded by a premier team of life science investors including The Column Group, OrbiMed, 5AM Ventures and Third Rock Ventures.
IGENICA
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2009-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.igenica.com
Total Employee:
11+
Status:
Active
Contact:
6506974900
Email Addresses:
[email protected]
Total Funding:
80.6 M USD
Technology used in webpage:
Amazon Google Maps Google Maps API Amazon Virginia Region Amazon S3 CDN Amazon Elastic Load Balancing Amazon ELB North Virginia
Similar Organizations
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Igenica
OrbiMed
OrbiMed investment in Series C - Igenica
Third Rock Ventures
Third Rock Ventures investment in Series C - Igenica
The Column Group
The Column Group investment in Series C - Igenica
5AM Ventures
5AM Ventures investment in Series C - Igenica
Third Rock Ventures
Third Rock Ventures investment in Series C - Igenica
5AM Ventures
5AM Ventures investment in Series C - Igenica
OrbiMed
OrbiMed investment in Series C - Igenica
The Column Group
The Column Group investment in Series C - Igenica
The Column Group
The Column Group investment in Series B - Igenica
Official Site Inspections
http://www.igenica.com Semrush global rank: 2.89 M Semrush visits lastest month: 5.61 K
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Igenica"
Igenica Biotherapeutics Inc - Company Profile and News
Company profile page for Igenica Biotherapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»
Igenica - VentureRadar
Igenica, Inc. is a biopharmaceutical company pioneering breakthrough antibody-based cancer medicines. The company has integrated innovative technology platforms to address the major …See details»
Igenica Biotherapeutics - Products, Competitors, Financials, …
About Igenica Biotherapeutics Igenica is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only …See details»
Igenica Biotherapeutics, Inc.: Contact Details and Business Profile
Igenica Biotherapeutics, Inc. is a Biotechnology, Pharmaceuticals, and Drug Discovery company located in Burlingame, California with $8.40 Million in revenue and 3 employees. Find top …See details»
Igenica Biotherapeutics, Inc.:Company Profile & Technical Research ...
Igenica Biotherapeutics, Inc. is a company that provides Antibody, Biology, Biomedicine and more. Igenica Biotherapeutics, Inc. is headquartered in United States California. Igenica …See details»
Igenica Inc. - BioCentury Company Profiles - BCIQ
Aug 9, 2022 Igenica Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Igenica Biotherapeutics (immune oncology asset) 2025 ... - PitchBook
Information on acquisition, funding, investors, and executives for Igenica Biotherapeutics (immune oncology asset). Use the PitchBook Platform to explore the full profile.See details»
Igenica Biotherapeutics CEO, Founder, Key Executive Team, Board …
Explore {Igenica Biotherapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Igenica - Funding, Financials, Valuation & Investors - Crunchbase
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.See details»
Igenica - EquityNet
Igenica is a biopharmaceutical company dedicated to the discovery and development of breakthrough antibody-based therapeutics for the treatment of cancer. Although recombinant …See details»
Igenica Raises $24 Million - venturecapitaljournal.com
Jun 11, 2010 Igenica Inc., a developer of antibody-based cancer medicines, has raised $24 million in Series B funding. Return backers include The Column Group, OrbiMed Advisors and …See details»
Igenica Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Igenica Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 4 news, and 6 literature, Drug:IGN-786, IGN-523.See details»
Bay Area's Igenica, Inc. Follows Genentech Into Antibody
Apr 14, 2014 Squint a little, and it’s easy to see the first five years of Burlingame, CA-based Igenica Biotherapeutics as a speeded-up version of the evolution of biotech pioneer …See details»
Igenica - Contacts, Employees, Board Members, Advisors & Alumni
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.See details»
Pierre Fabre Acquires Promising Assets From Igenica, Inc. In
May 24, 2017 CASTRES, France-- (BUSINESS WIRE)--Pierre Fabre, the 2 nd largest French private Pharmaceutical group, today announced the signature of a definitive purchase …See details»
Igenica, Inc. Enters Into A Strategic Oncology Research ... - BioSpace
Oct 28, 2015 Igenica Biotherapeutics, Inc., a company focused on the discovery and development of innovative antibody-based therapies for the treatment of cancer, announced …See details»
Igenica Biotherapeutics - Assets - Crunchbase Company Profile
Igenica Biotherapeutics is the biotechnology company.Where is Igenica Biotherapeutics - Assets's headquarters? Igenica Biotherapeutics - Assets is located in Burlingame, California, United …See details»
Igenica Company Profile - Life Science Intelligence
Antibody-based cancer medicinesSubscribe Now Request Info Antibody-based cancer medicines Technology/product details Revenue projections Capital raised to date Growth strategy …See details»
Igenica to Advance mAb Platform with $33M Series C
Jun 13, 2012 Privately held Igenica Inc. hooked Third Rock Ventures LLC, which traditionally launches biotech start-ups, as lead investor in a $33 million Series C to propel initial …See details»
Pierre Fabre to buy Igenica Biotherapeutics’ assets for treating …
May 25, 2017 French private pharmaceutical group Pierre Fabre has signed a new definitive purchase agreement to acquire several assets from US biotechnology company Igenica …See details»